SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010878
Filing Date
2021-08-09
Accepted
2021-08-09 07:38:21
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20210630x10q.htm   iXBRL 10-Q 2125011
2 EX-31.1 vygr-20210630xex31d1.htm EX-31.1 13675
3 EX-31.2 vygr-20210630xex31d2.htm EX-31.2 13763
4 EX-32.1 vygr-20210630xex32d1.htm EX-32.1 10699
5 GRAPHIC vygr-20210630x10q006.jpg GRAPHIC 112705
  Complete submission text file 0001558370-21-010878.txt   7126033

Data Files

Seq Description Document Type Size
6 EX-101.SCH vygr-20210630.xsd EX-101.SCH 45410
7 EX-101.CAL vygr-20210630_cal.xml EX-101.CAL 52576
8 EX-101.DEF vygr-20210630_def.xml EX-101.DEF 146209
9 EX-101.LAB vygr-20210630_lab.xml EX-101.LAB 400550
10 EX-101.PRE vygr-20210630_pre.xml EX-101.PRE 286632
11 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20210630x10q_htm.xml XML 1115439
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 211154648
SIC: 2836 Biological Products, (No Diagnostic Substances)